title: Comparison between the effects of forskolin and calcitonin on bone resorption and osteoclast morphology in vitro.
abstract: The adenylate cyclase activator forskolin (1-10 mumol/L) inhibited 45Ca release from parathyroid hormone (PTH; 10 nmol/L) stimulated prelabeled neonatal mouse calvaria in short term culture (24 h). This effect of forskolin was potentiated by rolipram, Ro 20-1724, and isobutyl-methylxanthine, three structurally different inhibitors of cyclic AMP phosphodiesterase. Forskolin (10 mumol/L) and calcitonin (30 mU/mL) inhibited the mobilization of stable calcium and inorganic phosphate as well as the release of the lysomal enzymes beta-glucuronidase and beta-N-acetylglucosaminidase from PTH-stimulated unlabeled bones. Osteoclasts in PTH-stimulated calvaria showed active ruffled borders with numerous membrane infoldings. Treatment of PTH-stimulated bones with forskolin and calcitonin resulted in a rapid (2 h) loss of the active ruffled border. In addition, forskolin and calcitonin induced similar changes with respect to the number and size distribution of cytoplasmic vesicles in PTH-activated osteoclasts. After 24 h, all signs of osteoclast inactivation were still prominent, whereas after 48 h of treatment with forskolin or calcitonin, the reappearance of a ruffled border on a number of osteoclasts signaled an escape from the inhibitory action of both calcitonin or forskolin. These data indicate that forskolin inhibits bone resorption by a cyclic AMP dependent mechanism and that the effect of forskolin and calcitonin on bone resorption and osteoclast morphology are comparable. These observations lend further support to the view that cyclic AMP may be an intracellular mediator of the inhibitory action of calcitonin on multinucleated osteoclasts.
authors.affiliation: Department of Oral Pathology, University of Umea, Sweden.
authors.forename: U H
authors.initials: UH
authors.lastname: Lerner
authors.forename: M
authors.initials: M
authors.lastname: Ransjö
authors.forename: K
authors.initials: K
authors.lastname: Klaushofer
authors.forename: H
authors.initials: H
authors.lastname: Hörandner
authors.forename: O
authors.initials: O
authors.lastname: Hoffmann
authors.forename: E
authors.initials: E
authors.lastname: Czerwenka
authors.forename: K
authors.initials: K
authors.lastname: Koller
authors.forename: M
authors.initials: M
authors.lastname: Peterlik
mesh_terms: D000118:Acetylglucosaminidase / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001862:Bone Resorption / Q000188:drug therapy*; D002116:Calcitonin / Q000494:pharmacology*; D005576:Colforsin / Q000494:pharmacology*; D046508:Culture Techniques; D005966:Glucuronidase / Q000378:metabolism; D008247:Lysosomes / Q000201:enzymology; D051379:Mice; D010010:Osteoclasts / Q000187:drug effects* / Q000648:ultrastructure; D010281:Parathyroid Hormone / Q000502:physiology
chemical_list: D010281:Parathyroid Hormone; D005576:Colforsin; D002116:Calcitonin; D005966:Glucuronidase; D000118:Acetylglucosaminidase